Zhejiang Hisoar Pharmaceutical Co.,Ltd.’s Net Profit Dropped 89.2% in First Half of 2023

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net profit of 18.4 million yuan in the first half of 2023, down 89.2% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 18.5% year-on-year.

At the end of the reporting period, it had 8.7 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 30.6%.